ICU Medical (ICUI) Tops Q3 EPS by 18c, FY Guidance Tops Views

ICU Medical (NASDAQ: ICUI) reported Q3 EPS of $1.35, $0.18 better than the analyst estimate of $1.17. Revenue for the quarter came in at $97.1 million versus the consensus estimate of $93.04 million.

GUIDANCE:

ICU Medical sees FY2016 EPS of $4.80-$4.90. ICU Medical sees FY2016 revenue of $375-380 million, versus the consensus of $372 million.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Genco rejects Diana Shipping takeover bid as undervalued
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance